Home/Filings/4/0000950170-23-068922
4//SEC Filing

Sullivan Eddie Joe 4

Accession 0000950170-23-068922

CIK 0001833214other

Filed

Dec 7, 7:00 PM ET

Accepted

Dec 8, 8:00 AM ET

Size

4.6 KB

Accession

0000950170-23-068922

Insider Transaction Report

Form 4
Period: 2023-12-07
Sullivan Eddie Joe
DirectorPRESIDENT
Transactions
  • Purchase

    Common Stock

    2023-12-07$0.88/sh+1,740$1,5315,232,304 total
Footnotes (1)
  • [F1]Represents 1,740 shares of the Issuer's common stock, par value $0.0001 per share, acquired by the reporting person in an open market transaction.

Documents

1 file

Issuer

SAB Biotherapeutics, Inc.

CIK 0001833214

Entity typeother

Related Parties

1
  • filerCIK 0001889712

Filing Metadata

Form type
4
Filed
Dec 7, 7:00 PM ET
Accepted
Dec 8, 8:00 AM ET
Size
4.6 KB